Hirtle Callaghan & Co’s The ExOne Company XONE Stock Holding History

Hirtle Callaghan & Co’s Portfolio XONE Stock Details XONE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-35	Closed	-$1K	–	395
2014 Q4	$1K	Sell	35 -500	-93%	-$10K	﹤0.01%	550
2014 Q3	$11K	Hold	535	–	–	﹤0.01%	457
2014 Q2	$21K	Buy	+535	New	+$16.6K	﹤0.01%	459

Other funds holding XONE

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bolton LP Greenwich, Connecticut $259M AUM 30.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Hirtle Callaghan & Co's XONE Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of The ExOne Company (XONE) in Q1 2015, closing a stake of 35 shares — an estimated $1K sold.

Hirtle Callaghan & Co first reported a position in XONE in Q2 2014 and held it in 3 quarters. The position peaked at $21K in Q2 2014. 72 funds tracked by Wall St. Rank hold XONE as of Q1 2015.

Hirtle Callaghan & Co reported no remaining The ExOne Company position as of Q1 2015 after selling out during the quarter.
Hirtle Callaghan & Co sold 35 The ExOne Company shares in Q1 2015, an estimated $1K.
Hirtle Callaghan & Co first reported a position in The ExOne Company in Q2 2014 and held it in 3 quarters.
Hirtle Callaghan & Co's The ExOne Company position peaked at $21K in Q2 2014.
72 funds tracked by Wall St. Rank held The ExOne Company as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.